Skip to content
Home
About
Consulting
In Office Infection Control Consulting
eLearning
Online Consulting
Education Programs
Skype Consulting
Shop
All Products
eLearning Classes
Training Programs – DVD
Training Manuals
Newsletters
Blog
Germ Catcher Blog
Infection Control
CDC News
EID Journal
Events
Log In
Contact
Menu
Home
About
Consulting
In Office Infection Control Consulting
eLearning
Online Consulting
Education Programs
Skype Consulting
Shop
All Products
eLearning Classes
Training Programs – DVD
Training Manuals
Newsletters
Blog
Germ Catcher Blog
Infection Control
CDC News
EID Journal
Events
Log In
Contact
$
0.00
0
Cart
Experts call for risk-benefit talks on lab-modified pathogens
By
Jim Wappes
July 15, 2014
3:22 pm
Lisa Schnirring | Staff Writer | CIDRAP NewsJul 15, 2014Their consensus statement calls for better tools to weigh risks and benefits.Share Tweet Email Print & PDF
Lisa Schnirring | Staff Writer | CIDRAP News
Jul 15, 2014
Their consensus statement calls for better tools to weigh risks and benefits.
Share
Tweet
Email
Print & PDF
Facebook
Twitter
LinkedIn
Pinterest
Jim Wappes
All Posts »
Prev
Previous
News Scan for Jul 15, 2014
Next
Wholesale roster change coming for US biosecurity board
Next